Re: Van Asten et al.: No CFH/ARMS2 interaction with omega-3 fatty acids, low vs high zinc, or ß-carotene versus Lutein and Zeaxanthin on progression of age-related macular degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18 (Ophthalmology. 2019;126:1541-1548).

Zanke, Brent; Kustra, Rafal

Re: Van Asten et al.: No CFH/ARMS2 interaction with omega-3 fatty acids, low vs high zinc, or ß-carotene versus Lutein and Zeaxanthin on progression of age-related macular degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18 (Ophthalmology. 2019;126:1541-1548).

Zanke, Brent; Kustra, Rafal.

Afiliación

Zanke B; Arctic Medical Laboratories, Grand Rapids, Michigan. Electronic address: bzanke@me.com.
Kustra R; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Ophthalmology ; 127(3): e19, 2020 03.

Article en En | MEDLINE | ID: mdl-32087876

Asunto(s)

Ácidos Grasos Omega-3; Degeneración Macular; Suplementos Dietéticos; Humanos; Luteína; Proteínas; Zeaxantinas; Zinc; beta Caroteno

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácidos Grasos Omega-3 / Degeneración Macular Límite: Humans Idioma: En Revista: Ophthalmology Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google